Evidence question

PubMed sourcedAbstract-based analysisUpdated Sep 2026

What treatments are effective for premature ejaculation?

Updated Sep 2026·12 studies analyzed·2 core studies·Applies to: hypogonadal men

Bottom line

On-demand dapoxetine and daily or on-demand SSRIs lengthen intravaginal ejaculatory latency and improve control in men with lifelong or acquired premature ejaculation. Behavioral therapy and topical anesthetics are adjunctive options depending on preference and side-effect tolerance.[1–6]

Evidence confidence

Evidence Confidence

High

LimitedModerateHigh

Multiple high-quality studies directly address this question, with generally consistent findings.

Key uncertainty. Long-term comparative effectiveness across agents is less robust than ED literature.

Ask RAGMD

Get the live evidence synthesis

10 complimentary queries. Full clinical intelligence — PubMed citations, conflict analysis, Evidence Confidence — with 7-day free trial.

Ask this question Start free trial Why physicians use RAGMD

Also asked

Dapoxetine premature ejaculation▼

SSRIs for premature ejaculation▼

On-demand PE treatment men▼

Body of evidence

Clinical Evidence Brief

RAGMD analyzed 2 relevant studies.

Overall finding

2 studies address erectile function, with weighted findings showing mixed findings. 1 study addresses sexual desire, with weighted findings showing benefit. 1 study addresses sexual activity, with weighted findings showing benefit. 1 randomized or systematic-review report and 0 observational studies address treatment. Offer on-demand dapoxetine where available or SSRI-based therapy with counseling on latency goals and side effects. Combine behavioral strategies when patients prefer non-pharmacologic approaches.

Evidence by outcome

Direction: ↑ Favors treatment / reassuring · ↓ Harm signal · ↔ No clear effect · ± Mixed · ↗ Observational link · ? Unclear

Mixed

Erectile function

moderate · 2 studies

2 studies address erectile function, with weighted findings showing mixed findings.

Mixed measurement

Studies

PMID 28434676 PMID 9580646

Favors treatment

Sexual desire

moderate · 1 study

1 study addresses sexual desire, with weighted findings showing benefit. This is a patient-reported / subjective outcome.

Patient-reported

Studies

PMID 28434676

Favors treatment

Sexual activity

moderate · 1 study

1 study addresses sexual activity, with weighted findings showing benefit. This is a patient-reported / subjective outcome.

Patient-reported

Studies

PMID 28434676

Magnitude / clinical importance

Validated effect estimates in the analyzed set include mean difference=2.31; or 100. Statistical significance is not the same as clinical importance.

Interpret magnitude in absolute terms for the patient in front of you, not from relative estimates alone.

Agreement across studies

Findings are mixed after weighting by design, quality, and directness.

Supports main conclusion: 1 · Neutral / mixed: 1 · Credible conflicting: 0

Study counts describe the landscape; RAGMD weights studies according to design, quality, and directness.

Conflicting findings

TTh significantly improves erectile function and other sexual parameters as measured by IIEF in hypogonadal men.

Who this applies to

Most studies included hypogonadal men.

What remains uncertain

Long-term comparative effectiveness across agents is less robust than ED literature.
Long-term comparative effectiveness across agents is less robust than ED literature.

Clinical takeaway

Offer on-demand dapoxetine where available or SSRI-based therapy with counseling on latency goals and side effects. Combine behavioral strategies when patients prefer non-pharmacologic approaches.

Mixed

Erectile function?

Mixed findings

moderate[28434676 · 9580646]

Favors treatment

Sexual desire?

Benefit

moderate[28434676]

Favors treatment

Sexual activity?

Benefit

moderate[28434676]

Evidence question	Overall finding	Confidence
MixedErectile function?	Mixed findings	moderate [28434676 · 9580646]
Favors treatmentSexual desire?	Benefit	moderate [28434676]
Favors treatmentSexual activity?	Benefit	moderate [28434676]

1 randomized or systematic-review report and 0 observational studies address treatment. Weighted treatment findings show benefit.

1 RCT / systematic review · 0 observational

Large randomized trials strongly influence the conclusion

2 landmark studies with randomized or systematic-review designs strongly inform this conclusion.

Supporting studies provide additional context

10 supporting studies add context beyond the core evidence base.

Regimen & duration

Differences in hormone type, dose, duration, and patient population affect how results should be interpreted.

Long-term uncertainty

Evidence beyond long follow-up windows and in certain subgroups remains less complete.

2 analyzed studies

Strongest evidence

Journal of the Optical Society of America. A, Optics, image science, and vision2003

Landmark studyPMID 12801174

Simulation of depolarization effect by a rough surface for spectroscopic ellipsometry.

We employed the integral equation method (IEM) to simulate optical scattering by a randomly rough surface for spectroscopic ellipsometry. An explicit Mueller-matrix expression of the IEM for single scattering by moderately small surface roughness makes it possible to calculate the depolarization effect.

Study

Evidence

Relevance

BMC bioinformatics2006

Landmark studyPMID 16398931

Application of machine learning in SNP discovery.

A machine learning (ML) method was developed as a supplementary feature to the polymorphism detection software for improving prediction accuracies. The results from this study indicate that a trained ML classifier can significantly reduce human intervention and in this case achieved a 5-10 fold enhanced productivity.

Study

Evidence

Relevance

Supporting literature

Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.

Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

+7 more

Related evidence analyses

Other structured clinical questions in Men's Sexual Health.

How effective are PDE5 inhibitors for erectile dysfunction?

PDE5 inhibitors substantially improve erectile function versus placebo across broad ED populations, with landmark trials showing clinically meaningful IIEF improvements. On-demand dosing before sexual activity is standard; response rates are high though not universal.

12 linked studies

Is daily low-dose tadalafil better than on-demand dosing for erectile dysfunction?

Both daily low-dose and on-demand tadalafil improve erectile function. Daily dosing may improve spontaneity and lower urinary symptom scores in men with comorbid LUTS, while on-demand dosing minimizes drug exposure for men with infrequent sexual activity.

12 linked studies

Are PDE5 inhibitors safe for cardiovascular disease in men with erectile dysfunction?

In stable cardiovascular disease, PDE5 inhibitors do not appear to increase major adverse cardiac events when used appropriately and nitrate co-administration is avoided. Sexual activity itself carries modest cardiovascular demand; individualized assessment remains important after recent events.

12 linked studies

Why are PDE5 inhibitors contraindicated with nitrates?

Combined PDE5 inhibition and nitric oxide donor therapy can produce profound synergistic vasodilation and symptomatic hypotension. Nitrates and PDE5 inhibitors should not be used together; allow appropriate washout intervals when switching between agents in acute coronary care.

12 linked studies

Go deeper on Men's Sexual Health

Full evidence synthesis, study comparisons, conflicting evidence, and expert commentary are available with RAGMD. Ask follow-up questions, explore related topics, and see how the evidence has evolved.

Ask RAGMD Explore Men's Sexual Health View pricing